Tokyo Tape
Sign in
← Wakamoto Pharmaceutical

Quarterly report · Q2

4512.TEDINET S100S8LR
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥3.6bn2023-04-01 → 2023-09-30StandaloneNet sales
Revenue¥8.7bn2022-04-01 → 2023-03-31StandaloneNet sales (5-year summary)
Revenue¥4.0bn2022-04-01 → 2022-09-30StandaloneNet sales
Operating income−¥328m2023-04-01 → 2023-09-30StandaloneOperating income
Operating income−¥86m2022-04-01 → 2022-09-30StandaloneOperating income
Ordinary income−¥320m2023-04-01 → 2023-09-30StandaloneOrdinary income
Ordinary income¥243m2022-04-01 → 2023-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥28m2022-04-01 → 2022-09-30StandaloneOrdinary income
Profit before tax−¥170m2023-04-01 → 2023-09-30StandaloneIncome before income taxes
Profit before tax−¥28m2022-04-01 → 2022-09-30StandaloneIncome before income taxes
Net income−¥223m2023-04-01 → 2023-09-30StandaloneProfit loss
Net income¥138m2022-04-01 → 2023-03-31StandaloneNet income loss (5-year summary)
Net income−¥22m2022-04-01 → 2022-09-30StandaloneProfit loss
Total assets¥15.8bnat 2023-09-30StandaloneAssets
Total assets¥15.7bnat 2023-03-31StandaloneAssets
Total assets¥14.7bnat 2022-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥3.8bnat 2023-09-30StandaloneLiabilities
Total liabilities¥3.8bnat 2023-03-31StandaloneLiabilities
Net assets / equity¥12.0bnat 2023-09-30StandaloneNet assets
Net assets / equity¥11.9bnat 2023-03-31StandaloneNet assets
Net assets / equity¥11.6bnat 2022-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥4.0bnat 2023-09-30StandaloneCash and deposits
Cash and deposits¥3.9bnat 2023-03-31StandaloneCash and deposits
Cash & equivalents¥4.0bnat 2023-09-30StandaloneCash and cash equivalents
Cash & equivalents¥3.9bnat 2023-03-31StandaloneCash and cash equivalents
Cash & equivalents¥3.6bnat 2022-09-30StandaloneCash and cash equivalents
Cash & equivalents¥3.2bnat 2022-03-31dStandaloneCash and cash equivalents
Operating cash flow¥109m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow¥632m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥254m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in operating activities
Investing cash flow¥78m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow¥17m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥150m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in investment activities
Financing cash flow−¥104m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow−¥2m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-6.422023-04-01 → 2023-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-9.322023-07-01 → 2023-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥3.982022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-0.622022-04-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-0.482022-07-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥32022-04-01 → 2023-03-31StandaloneDividend paid per share (5-year summary)
Equity ratio76.1%at 2023-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio75.8%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio78.6%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued34,838,000at 2023-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued34,838,000at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued34,838,000at 2022-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q2r_E00928-000Ethical Products Business Relatedreportable segmentrevenue2023-04-01 → 2023-09-30¥1.6bn
jpcrp040300-q2r_E00928-000Ethical Products Business Relatedreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.6bn
jpcrp040300-q2r_E00928-000Ethical Products Business Relatedreportable segmentsegment profit2023-04-01 → 2023-09-30−¥475m
jpcrp040300-q2r_E00928-000Global Sales Development Business Relatedreportable segmentrevenue2023-04-01 → 2023-09-30¥832m
jpcrp040300-q2r_E00928-000Global Sales Development Business Relatedreportable segmentrevenue external2023-04-01 → 2023-09-30¥832m
jpcrp040300-q2r_E00928-000Global Sales Development Business Relatedreportable segmentsegment profit2023-04-01 → 2023-09-30¥23m
jpcrp040300-q2r_E00928-000Otc Products Business Relatedreportable segmentrevenue2023-04-01 → 2023-09-30¥1.1bn
jpcrp040300-q2r_E00928-000Otc Products Business Relatedreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.1bn
jpcrp040300-q2r_E00928-000Otc Products Business Relatedreportable segmentsegment profit2023-04-01 → 2023-09-30¥96m
—segment totalrevenue2023-04-01 → 2023-09-30¥3.6bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥3.6bn
—segment totalsegment profit2023-04-01 → 2023-09-30−¥328m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥3.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥3.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30−¥328m
jpcrp040300-q2r_E00928-000Ethical Products Business Relatedreportable segmentrevenue2022-04-01 → 2022-09-30¥2.1bn
jpcrp040300-q2r_E00928-000Ethical Products Business Relatedreportable segmentrevenue external2022-04-01 → 2022-09-30¥2.1bn
jpcrp040300-q2r_E00928-000Ethical Products Business Relatedreportable segmentsegment profit2022-04-01 → 2022-09-30−¥205m
jpcrp040300-q2r_E00928-000Global Sales Development Business Relatedreportable segmentrevenue2022-04-01 → 2022-09-30¥949m
jpcrp040300-q2r_E00928-000Global Sales Development Business Relatedreportable segmentrevenue external2022-04-01 → 2022-09-30¥949m
jpcrp040300-q2r_E00928-000Global Sales Development Business Relatedreportable segmentsegment profit2022-04-01 → 2022-09-30¥45m
jpcrp040300-q2r_E00928-000Otc Products Business Relatedreportable segmentrevenue2022-04-01 → 2022-09-30¥850m
jpcrp040300-q2r_E00928-000Otc Products Business Relatedreportable segmentrevenue external2022-04-01 → 2022-09-30¥850m
jpcrp040300-q2r_E00928-000Otc Products Business Relatedreportable segmentsegment profit2022-04-01 → 2022-09-30¥37m
—segment totalrevenue2022-04-01 → 2022-09-30¥4.0bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥4.0bn
—segment totalsegment profit2022-04-01 → 2022-09-30−¥86m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥4.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥4.0bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30−¥86m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 530
ItemContextValueUnit
Operating incomePrior1YTDDuration_NonConsolidatedMember-85944000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000EthicalProductsBusinessRelatedReportableSegmentsMember1625652000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000OtcProductsBusinessRelatedReportableSegmentsMember1074671000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000GlobalSalesDevelopmentBusinessRelatedReportableSegmentsMember831909000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000RealEstateLeasingBusinessMember86155000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember3618388000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember3618388000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember3618388000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000EthicalProductsBusinessRelatedReportableSegmentsMember1625652000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000OtcProductsBusinessRelatedReportableSegmentsMember1074671000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000GlobalSalesDevelopmentBusinessRelatedReportableSegmentsMember831909000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000RealEstateLeasingBusinessMember86155000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember3618388000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember3618388000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Net salesCurrentYTDDuration_NonConsolidatedMember3618388000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000EthicalProductsBusinessRelatedReportableSegmentsMember-475494000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000OtcProductsBusinessRelatedReportableSegmentsMember95630000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000GlobalSalesDevelopmentBusinessRelatedReportableSegmentsMember23396000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E00928-000RealEstateLeasingBusinessMember28088000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember-328378000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember-328378000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-328378000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-11-13
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第129期第２四半期（自　2023年７月１日　至　2023年９月30日）
Company name cover pageFilingDateInstant
Original text (Japanese)わかもと製薬株式会社
Company name in english cover pageFilingDateInstantWAKAMOTO PHARMACEUTICAL CO.,LTD.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　五十嵐　新
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都中央区日本橋本町二丁目２番２号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)（０３）３２７９－０３７１（代表）
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)広報室長　　平井　友行
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都中央区日本橋本町二丁目２番２号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)（０３）３２７９－０３７１（代表）
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)広報室長　　平井　友行
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE00928
Fund codeFilingDateInstant－
Security codeFilingDateInstant45120
Filer name in japaneseFilingDateInstant
Original text (Japanese)わかもと製薬株式会社
Filer name in englishFilingDateInstantWAKAMOTO PHARMACEUTICAL CO.,LTD.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式
Accounting standardsFilingDateInstantJapan GAAP

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2023-03-31pass
balance sheet identitynon_consolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2023-09-30pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flownon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · revenuenon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2023-09-30pass